METHYLPREDNISOLONE ACETATE injection, suspension アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

methylprednisolone acetate injection, suspension

physicians total care, inc. - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 40 mg in 1 ml - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension usp is indicated as follows: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with can

METHYLPREDNISOLONE ACETATE injection, suspension アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

methylprednisolone acetate injection, suspension

rebel distributors corp - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 40 mg in 1 ml - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension, usp is indicated as follows: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance) congenital adrenal hyperplasia, hypercalcemia associated with c

METHYLPHENIDATE HYDROCHLORIDE tablet アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

methylphenidate hydrochloride tablet

bionpharma inc. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 5 mg - attention deficit disorders (previously known as minimal brain dysfunction in children). other terms being used to describe the behavioral syndrome below include: hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction. methylphenidate hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. specif

365 WHOLE FOODS MARKET ANTICAVITY/ANTIGINGIVITIS MOUTHWASH- eucalyptol, menthol, methyl salicylate, thymol, sodium fluoride mout アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

365 whole foods market anticavity/antigingivitis mouthwash- eucalyptol, menthol, methyl salicylate, thymol, sodium fluoride mout

whole foods market, inc. - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), thymol (unii: 3j50xa376e) (thymol - unii:3j50xa376e), eucalyptol (unii: rv6j6604tk) (eucalyptol - unii:rv6j6604tk) - uses • aids in the prevention of dental cavities. • helps remove plaque that leads to gingivitis, an early form of gum disease. • the combined daily use of a fluoride preventative treatment rinse and a fluoride toothpaste can help reduce the incidence of dental cavities. uses • aids in the prevention of dental cavities. • helps remove plaque that leads to gingivitis, an early form of gum disease. • the combined daily use of a fluoride preventative treatment rinse and a fluoride toothpaste can help reduce the incidence of dental cavities.

365 WHOLE FOODS MARKET ANTIGINGIVITIS MOUTHWASH- eucalyptol, menthol, methyl salicylate, thymol mouthwash アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

365 whole foods market antigingivitis mouthwash- eucalyptol, menthol, methyl salicylate, thymol mouthwash

whole foods market, inc. - thymol (unii: 3j50xa376e) (thymol - unii:3j50xa376e), eucalyptol (unii: rv6j6604tk) (eucalyptol - unii:rv6j6604tk), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - helps remove plaque that leads to gingivitis, an early form of gum disease. adults and children 12 years of age and older: vigorously swish 20ml of rinse between your teeth twice a day for 30 seconds and then spit out. • do not swallow the rinse • children under 12 years of age: do not use/consult a doctor.

MOUTHWASH- menthol, methyl salicylate, thymol liquid アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

mouthwash- menthol, methyl salicylate, thymol liquid

orazen inc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), thymol (unii: 3j50xa376e) (thymol - unii:3j50xa376e), eucalyptol (unii: rv6j6604tk) (eucalyptol - unii:rv6j6604tk), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - purpose antigingivitis, antiplaque uses helps reduce plaque that leads to - gingivitis - bleeding gums

METHYLPREDNISOLONE MYLAN 500 MG イスラエル - 英語 - Ministry of Health

methylprednisolone mylan 500 mg

genmedix , israel - methylprednisolone as hemisuccinate - lyophilized powder for injection - methylprednisolone as hemisuccinate 500 mg - methylprednisolone - methylprednisolone mylan is indicated to treat any condition in which iv corticosteroid treatment is required such as: endocrine disorders, rheumatic disorders, collagen diseases, immune complex diseases, dermatologic diseases, allergic states, ophthalmic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, management of neoplastic diseases, edematous states, nervous system disorders and organ transplantation

DIMETHYL FUMARATE TEVA 240 MG イスラエル - 英語 - Ministry of Health

dimethyl fumarate teva 240 mg

teva israel ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimethyl fumarate - dimethyl fumarate teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis

DIMETHYL FUMARATE TEVA 120 MG イスラエル - 英語 - Ministry of Health

dimethyl fumarate teva 120 mg

teva israel ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimethyl fumarate - dimethyl fumarate teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis

METHYLPREDNISOLONE- methylprednisolone tablet アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

methylprednisolone- methylprednisolone tablet

a-s medication solutions - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - methylprednisolone tablets are indicated in the following conditions: - endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia hypercalcemia associated with cancer nonsuppurative thyroiditis primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia hypercalcemia associated with cancer nonsuppurative thyroiditis - rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected ca